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Ischemia/reperfusion injury associated with kidney
transplantation induces profound acute injury, influences
early graft function, and affects long-term graft outcomes. To
determine whether renal dendritic cells play any role during
initial innate ischemia/reperfusion injury and the subsequent
development of adaptive immune responses, we studied the
behavior and function of renal graft and host infiltrating
dendritic cells during early and late phases of renal ischemia/
reperfusion injury. Wild type to green fluorescent protein
(GFP) transgenic rat kidney transplantation was performed
with and without 24-h cold storage. Ischemia/reperfusion
injury in cold-stored grafts resulted in histopathological
changes of interstitial fibrosis and tubular atrophy by 10
weeks, accompanied by upregulation of mRNAs of mediators
of interstitial fibrosis and inflammation. In normal rat kidneys,
we identified two populations of renal dendritic cells,
predominant CD103CD11b/cþ and minor CD103þCD11b/cþ
cells. After transplantation without cold storage, grafts
maintained CD103 but not CD103þ GFP-negative renal
dendritic cells for 10 weeks. In contrast, both cell subsets
disappeared from cold-stored grafts, which associated with
a significant GFP-expressing host CD11b/cþ cell infiltration
that included CD103þ dendritic cells with a TNF-a–producing
phenotype. These changes in graft/host dendritic cell
populations were associated with progressive infiltration of
host CD4þ T cells with effector/effector-memory phenotypes
and IFN-c secretion. Thus, renal graft ischemia/reperfusion
injury caused graft dendritic cell loss and was associated with
progressive host dendritic cell and T-cell recruitment.
Renal-resident dendritic cells might function as a protective
regulatory network.
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Although significant improvements have been achieved in
early transplant outcomes, progressive deterioration of renal
allograft function and late allograft loss remain as major
impediments to long-term successful kidney transplantation
(KTx), with little clinical progress for many years.1,2 Late
graft loss typically associates with progressive renal dysfunc-
tion, proteinuria, and hypertension, and is accompanied by
histopathological findings of interstitial fibrosis, tubular
atrophy, vascular occlusive changes, and glomerulosclero-
sis.2–5 Recently, these changes (formerly referred to chronic
allograft nephropathy) have been renamed and redefined in
histological terms as interstitial fibrosis and tubular atrophy
(IF/TA) without evidence of any specific etiology.6 The
incidence of IF/TA is as high as 50% of kidney transplants
at 1 year, 70% at 2 year, and nearly universal after 10 year of
KTx.7–9 As there is neither an effective therapy, nor proven
preventive strategies, IF/TA and late graft loss remain as a
significant clinical problem in the field.
Ischemia/reperfusion injury (I/R) of the kidney graft is a
leading cause of late graft loss and earlier development of
IF/TA. Because of the current shortage of organs for trans-
plantation, the donor pool has been expanded with the use of
marginal donors (e.g., old donors, non-heart beating donors,
grafts with prolonged cold storage), and grafts from these
donors have a higher incidence of severe cold I/R injury and
subsequent IF/TA development. During the acute phase,
renal I/R injury presents a cascade of inflammatory events
involving multiple interconnected factors, including peri-
tubular capillary endothelial cell injury and disturbances of
microvascular circulation, production and release of reactive
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oxygen species and inflammatory mediators, and extra-
vasation of host inflammatory cells. However, the mechan-
isms of ongoing fibroinflammatory changes in the late phase
of I/R injury are yet to be identified.
Dendritic cells (DCs) function in and interact between the
innate and adaptive arms of the immune system. In the
normal kidney, DCs together with macrophages are major
constituents of the renal mononuclear phagocyte system, and
widely distributed throughout the interstitium.10–12 These
populations represent substantial heterogeneity and plastic-
ity, and studies aiming the distinction of two populations
based on cell surface markers have shown complicated
pictures.13–16 They often co-express DC markers (DCSIGN,
CD11c) and macrophage markers (CD68, F4/80), suggesting
their overlapping cellular function in the kidney. Although
renal DCs have been shown to have key roles in many renal
diseases,14,17,18 little is known about their function during
KTx-induced I/R injury and the subsequent chronic
inflammatory immune reactions leading to IF/TA. Several
previous studies have aimed to determine in vivo functional
roles of renal mononuclear phagocytes, in particular DCs, in
various kidney disease models by actively eliminating DCs
with liposome clodronate or using the CD11c-DTR mouse,
and showed contradictory results. Renal DCs are protective
in cisplatin-induced acute kidney injury19 and nephrotoxic
nephritis.20 On the contrary, they are proinflammatory and
detrimental in obstructive nephropathy21,22 and chronic
glomerulonephritis.23–25 In the model of renal warm
ischemia, cell population(s) that are depleted by liposome
clodronate have protective roles,26 whereas the same
liposome clodronate-depleted population(s) or CD11cþ cells
depleted in CD11c-DRT mouse are shown to be detri-
mental.13,27,28 These conflicting outcomes might be due to
different experimental settings or functions of non-DC
populations, as these DC deletion methods are not
completely specific for DCs.21,29,30 However, contradictory
results in these experiments could be explained by the
different roles of kidney-resident DCs and locally recruited
systemic DCs, and by the difficulty to differentiate two DC
populations in these studies, as both the populations could be
influenced by the depletion methods. We hypothesized that
renal graft–resident DCs and infiltrating host DCs might have
different functional roles in acute innate and subsequent
chronic phases of renal I/R injury. Accordingly, using the
green fluorescent protein (GFP) transgenic rat KTx model,
the aim of this study was to understand the roles of kidney-
resident DCs by examining the alteration of renal DCs in the
early and late phases of renal I/R injury, and by characterizing
recruited host DCs and other host cells.
RESULTS
Two types of kidney-resident DCs are identified in the rats
To characterize kidney-resident DCs, naı¨ve rat kidney
leukocytes were analyzed by flow cytometry (FCM) and
immunohistochemistry (IHC). FCM of isolated renal
CD45þ cells revealed that the major leukocyte population
in normal kidneys was CD11b/cþ cells, followed by NK cells,
T cells, and NKT cells (Figure 1a). IHC of naı¨ve kidney
showed that CD11b/cþ cells form a contiguous network
throughout the entire kidney interstitium (Figure 1c, upper),
suggesting that these cells were relevant to renal DCs as
previously reported both in mice and in humans.10–12,14
Further analysis of CD11b/cþ renal DCs showed that they
expressed CD4, CD86, and MHC class II, but were negative
for CD62L (Figure 1b). Subpopulation (B10%) of CD11b/
cþ renal DCs also expressed CD103, which were scarcely
found in the interstitium (Figure 1c, lower). These results
indicate the presence of two subsets of DCs, predominant
CD103CD11b/cþ and minor 103þCD11b/cþ populations,
in naı¨ve rat kidneys.
I/R injury results in fibroinflammatory changes in the
kidney grafts
Orthotopic syngeneic KTx was conducted using GFP
transgenic rats as recipients and wild type (WT) as donors
with static cold storage of kidney grafts for 24 h in UW
(University of Wisconsin) solution (24h-CS group). Donor
and recipient leukocytes in the kidney grafts were analyzed
with a comparison to control grafts that were transplanted
immediately (no-CS group). Robust mRNA upregulation for
tumor necrosis factor-a (TNF-a), interleukin (IL)-6, induc-
ible nitric oxide synthase, and IL-10 at 3 h after transplanta-
tion was seen in 24h-CS grafts, as we have previously
reported31–33 (Figure 2a). In contrast, no-CS grafts showed
negligible mRNA levels for these mediators (Figure 2a). In
addition, host neutrophil infiltration was significantly
increased in 24h-CS grafts, whereas they were only occasion-
ally seen in no-CS grafts at 12 h after KTx (Figure 2b).
At 4 weeks after KTx, no-CS grafts showed CCr levels
comparable with those of normal unoperated animals
(1.65±0.3ml/min), whereas 24h-CS grafts showed signifi-
cantly reduced CCr levels (0.26±0.2ml/min) with consider-
able proteinuria.33
Histopathological analyses of 24h-CS grafts at 10 weeks
revealed patchy areas of chronic changes comprising tubular
atrophy, interstitial fibrosis, chronic inflammation, and lym-
phocytic infiltration, relevant to changes that were described
as IF/TA (Figure 3a). No evidence of arteritis was seen. In
contrast, in the control no-CS grafts, the glomeruli, tubules,
and vessels in general appeared unremarkable. Masson’s
Trichrome stain revealed significantly increased fibrotic area
in 24h-CS grafts (Figure 3a). Immunofluorescent stain also
showed intense a-smooth muscle actin expression in 24h-CS
grafts at 10 weeks, whereas control no-CS grafts showed
marginal a-smooth muscle actin expression.
Active proinflammatory and profibrotic reactions in
24h-CS kidney grafts at 10 weeks were confirmed with real-
time polymerase chain reaction. mRNA levels for inflamma-
tory cytokines, as well as regulated upon activation normal
T-cell expressed, and presumably secreted and IL-10 were signi-
ficantly increased in 24h-CS than in no-CS grafts (Figure 3b).
Transforming growth factor-b, a key mediator in the
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Figure 1 |Renal-resident leukocytes in naı¨ve rat kidney. (a) Renal leukocytes were isolated from naı¨ve rat kidneys with collagenase
digestion and low-speed centrifugation, and analyzed by three to seven-color flow cytometry. CD45þ cells were gated, and kidney-resident
leukocyte composition was determined by surface marker expressions. Note that B70% of renal CD45þ leukocytes were CD103CD11b/
cþ and B10% CD103þCD11b/cþ . (b) Expression of various surface molecules on CD45þCD11b/cþ renal dendritic cells (DCs).
(c) Immunofluorescent stain of naı¨ve kidney revealed networks of CD11b/cþ cells throughout the entire kidney interstitium (red, upper).
CD103 expression was limited (red, lower). Representative images of N¼ 5 experiments. FSC, forward scatter; MHC, major histocompatibility
complex; NK, natural killer; NKT, natural killer T; SSC, side scatter.
40
#
30
20
10
0
No-CS
2000
25
20
15
10
5
0
No-CS
No-CS
24h-CS
24h-CS
1500
1000
500
0
24h-CS
No-CS 24h-CS
No-CS 24h-CS
No-CS 24h-CS
No-CS
IL-6
24h-CS
TNF-α
IL-1β
iNOS
IL-10
#
#
#
6 40
30
20
10
0
4
2
0
1000
800
600
400
200
0
Fo
ld
 in
cr
ea
se
/n
or
m
a
l k
id
ne
y
*
R
P-
1–
po
sit
ive
 c
e
lls
 p
er
 H
PF
Figure 2 | Early kidney graft injury caused by prolonged 24-h cold storage. Kidney graft samples were obtained at 3 and 12 h after wild
type (WT) to green fluorescent protein (GFP) kidney transplantation (KTx) with and without 24-h static cold storage in UW (University
of Wisconsin) solution (24h-CS and no-CS groups). (a) Samples at 3 h were analyzed for mRNA levels for proinflammatory mediators
with real-time polymerase chain reaction (RT-PCR). (b) Neutrophil infiltration (yellow arrows) in kidney grafts at 12 h was evaluated in
immunohistochemistry (IHC) with monoclonal antibody (mAb) for neutrophils (red, RP-1), and numbers of positively stained cells in high
power field (HPF) were determined. N¼ 3–4 for each group. *Po0.05 vs. no-CS controls. #Po0.005 vs. no-CS control. IL, interleukin; iNOS,
inducible nitric oxide synthase; TNF, tumor necrosis factor.
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progression of fibrosis, and collagen-1 also remarkably
increased in 24h-CS grafts. These results indicated that acute
innate I/R injury resulted in progressive fibroinflammatory
changes in syngeneic kidney grafts.
I/R injury associates with loss of graft renal DCs and
infiltration of host DCs/macrophages
To investigate the roles of renal DCs in acute I/R injury and
the development of chronic fibroinflammatory changes in the
WT to GFP KTx model, kidney-resident GFP DCs were
analyzed at early (3, 12 h) and late (4, 10 weeks) time points
by FCM of graft CD45þ cells. Percentages of donor
leukocytes (GFPCD45þ ) started to decrease after KTx,
and the reduction was significantly more in 24h-CS than in
no-CS grafts. At 10 weeks, only 11.3±4.9% of leukocytes in
24h-CS grafts were donor phenotype, whereas 46.3±10.2%
in no-CS grafts (Figure 4a). The reduction of donor leukocytes
was mainly due to progressive decreases of GFPCD11b/cþ
renal DCs, the major leukocyte population in native kidneys,
and at 10 weeks, frequencies of GFPCD11b/cþ renal DCs were
markedly lower in 24h-CS than in no-CS grafts (Figure 4b).
These results indicate that I/R injury in 24h-CS grafts resulted
in nearly total loss of graft renal DCs, while GFP renal DCs
were maintained in no-CS grafts.
Interestingly, further analysis of GFPCD11b/cþ renal
DCs revealed that the CD103CD11b/cþ DC subset
disappeared from 24h-CS, but not from no-CS, grafts. In
contrast, CD103þCD11b/cþ renal DCs disappeared from
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Figure 3 | Late kidney graft changes caused by ischemia/reperfusion (I/R) injury. (a) Histopathological findings: wild type (WT) to green
fluorescent protein (GFP) kidney transplantation (KTx) was performed with and without 24-h static cold storage in UW (University of
Wisconsin) solution (24h-CS and no-CS groups). Representative histological images of kidney grafts at 10 weeks are shown. (A) Hematoxylin
and eosin (H&E)-stained section of 24h-CS grafts shows areas of interstitial fibrosis and tubular atrophy (arrow) with chronic interstitial
inflammation. Tubular atrophy in the form of dilatation (‘thyroidization’) is also seen (arrowhead; H&E, original magnification  100).
Glomeruli contain globular material suggestive of protein. (B) In control no-CS grafts, tubules are intact with no significant increase in
interstitial fibrous tissue. Glomeruli are unremarkable (H&E, original magnification  100). (C) Masson’s trichrome stain reveals significant
fibrosis (blue) in 24h-CS grafts. (D) Control no-CS grafts show minimum fibrosis. (E, F) Immunofluorescent stain for a-SMA (red) shows
normal arterial a-SMA stain in no-CS grafts. The 24h-CS graft shows area of a-SMA–positive myofibroblasts with numerous GFPþ host
infiltrates. Blue: nuclear stain. Representative images from no-CS (N¼ 4) and 24h-CS (N¼ 5) grafts. (b) mRNA levels for inflammatory and
pro-fibrotic mediators in kidney grafts: real-time polymerase chain reaction (RT-PCR) was conducted using kidney graft samples obtained at
10 weeks. N¼ 2–5 for each group. *Po0.05 vs. no-CS controls. IL, interleukin; RANTES, regulated upon activation normal T-cell expressed
and presumably secreted; a-SMA, a-smooth muscle actin; TGF, transforming growth factor; TNF, tumor necrosis factor.
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both 24h-CS and no-CS grafts, regardless of I/R injury
(Figure 4c), suggesting different functional roles of CD103þ
and CD103 kidney DC populations. Concurrently, at 10
weeks, significant numbers of host GFPþCD11b/cþ cells
were found in 24h-CS grafts compared with no-CS grafts.
Particularly, host CD103þCD11b/cþ DCs were significantly
higher in 24h-CS than in no-CS grafts (19.6±2.0 vs.
6.7±1.9%; Figure 4c).
IHC at 10 weeks revealed that GFPCD11b/cþ DCs were
maintained and homogenously distributed in the interstitium
of no-CS grafts (Figure 5a–c). In contrast, these renal DCs
were not detected in 24h-CS grafts, and abundant
GFPþCD11b/cþ host cells were found among inflammatory
infiltrates (Figure 5d–f). Host CD11b/cþ cells could include
monocytes, macrophages, DCs, and neutrophils; however,
neutrophils (naphtholþ or RP-1þ ) were rare at 10 weeks
(data not shown), indicating that infiltrating host CD11b/cþ
cells in 24h-CS grafts at 10 weeks were mostly DC and
monocyte/macrophage populations. In IHC, host GFPþ
CD11b/cþ cells were found among inflammatory infiltrates
and did not localize to peritubular area to replace the original
renal DCs (Figure 5e), suggesting that functions of host
GFPþCD11b/cþ cells were different from those of kidney-
resident DCs.
Graft DC and host infiltrating CD11b/cþ cells produce TNF-a
As renal DCs have been shown to produce TNF-a in the
mouse warm I/R injury model,27 we examined whether renal-
resident graft DCs and/or host infiltrating DCs produced
TNF-a in KTx-induced I/R injury. TNF-a production was
exclusively seen on CD11b/cþ cells. At 12 h in 24h-CS grafts,
both GFP renal DCs and GFPþCD11b/cþ host infiltrates
produced TNF-a, and their frequencies were higher in host
GFPþCD11b/cþ cells (Figure 4d). At 10 weeks, 20.4±2.8%
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Figure 4 |CD11b/cþ cells in kidney grafts. After wild type (WT) to green fluorescent protein (GFP) kidney transplantation (KTx) with or
without 24-h cold storage in UW (University of Wisconsin) solution (24h-CS, no-CS groups), kidney grafts were obtained at 3 h, 12 h, 4 weeks,
and 10 weeks (N¼ 2–4 for each time point in no-CS and N¼ 4–6 in 24h-CS groups) for flow cytometry of CD45þ leukocytes isolated from
the kidney grafts. (a) Percentages of GFP cells in graft CD45þ leukocytes. Significant decreases of GFP graft cells in 24h-CS grafts
compared with no-CS grafts. *Po0.05, #Po0.005. (b) Percentages of GFPCD11b/cþ renal dendritic cells (DCs) in graft CD45þ leukocytes.
Graft-resident GFPCD11b/cþ DCs significantly decreased due to ischemia/reperfusion (I/R) injury in 24h-CS than in no-CS grafts. *Po0.05,
#Po0.005. (c) Flow cytometry of CD45þCD11b/cþ cells in kidney grafts. Donor GFPCD103þ DCs quickly disappeared from both 24h-CS
and no-CS grafts within 1 week. In contrast, donor GFPCD103 DCs disappeared from 24h-CS, but not from no-CS, grafts. At the
same time, host GFPþCD11b/cþ cells increased with time, and GFPþCD11b/cþCD103þ DCs significantly increased in 24h-CS grafts.
Representative histograms (upper) and bar graph showing percentages in CD45þCD11b/cþ -gated cells. *Po0.05. (d) In 24h-CS grafts, both
GFPCD11b/cþ renal DCs and GFPþCD11b/cþ infiltrates produced tumor necrosis factor-a (TNF-a) at 12 h, but the frequencies were
significantly higher in the host population. At 10 weeks, TNF-a was detected mostly in GFPþCD11b/cþ cells. *Po0.05.
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of host CD11b/cþ cells produced TNF-a, whereas remaining
small fractions (5.3±1.2%) of donor renal DCs were positive
for TNF-a. TNF-a–producing renal DCs were CD103
subtype.
Renal I/R injury results in continual host cell infiltration
In conjunction with the alteration in DC populations, GFPþ
host leukocytes infiltrated kidney grafts after KTx, and
percentages of host cells were significantly higher in 24h-CS
than in control no-CS grafts as early as 3 h after KTx. GFPþ
host cells in 24h-CS grafts further increased with time, and
nearly all of graft leukocytes became host phenotype by 10
weeks, while no-CS grafts showed significantly less GFPþ
host cells (88.7±4.9 vs. 53.7±10.2%; Figure 6a). Increases of
GFPþ host infiltration into kidney grafts were confirmed in
tissue sections, and 24h-CS grafts showed abundant GFPþ
cells at 10 weeks (Figure 6b).
Effector-memory type CD4þ T cells accumulate in kidney
grafts with I/R injury
FCM analysis of host infiltrates during early and late phases
of I/R injury revealed significant increase of CD3þ T-cell
frequencies in 24h-CS grafts at 4 and 10 weeks compared
with control no-CS kidney grafts (Figure 6c). IHC with anti-
CD3 mAb also confirmed numerous GFPþCD3þ cells
among infiltrates in 24h-CS grafts at 10 weeks (Figure 6d).
Characterization of CD3þ cells in kidney grafts revealed
gradual increases of CD4þ T cells with I/R injury. At
10 weeks, infiltrating GFPþ host T cells in 24h-CS grafts
were dominated by CD4þ T cells with significantly higher
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Figure 5 | Immunohistochemistry of CD11b/cþ cells in kidney grafts. Representative images of CD11b/c stain (red) in kidney grafts at 10
weeks are shown as merged (left panels), red channel (middle panels), and green channel (right panels). In the peritubular area, no-CS grafts
show numerous CD11b/cþGFP renal dendritic cells (DCs; red), whereas 24h-CS grafts show GFPþ host infiltrates (green) without CD11b/c-
expressing renal DCs. Instead, 24h-CS grafts show many GFPþCD11b/cþ host infiltrating DCs/monocytes. (a) No-CS grafts at 10 weeks
show persistence of CD11b/cþGFP renal DCs (red, blue arrows). (b) High-magnification image of CD11b/cþGFP renal DCs (blue arrow) in
the peritubular area. (c) High-magnification image of CD11b/cþGFP renal DCs (blue arrowhead) in the area of GFPþ infiltrates. (d) In
contrast, 24h-CS grafts at 10 weeks have nearly no donor renal DCs (GFPCD11b/cþ ) but have numerous CD11b/cþ GFPþ infiltrates
(double-positive yellow, yellow arrowhead). (e) High-magnification image of GFPþ infiltrates and loss of CD11b/cþ DCs in the peritubular
area (the insets in d). (f) High-magnification image of GFPþCD11b/cþ cells among host infiltrates (yellow arrowhead).
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CD4/CD8 ratios, compared with those in no-CS grafts
(1.8±0.4 vs. 0.7±0.2; Figure 7a and b). Majority of
GFPþCD3þ cells were CD62L negative and expressed low
molecular weight CD45 isoforms, indicating that they were
effector or effector-memory phenotype T cells (Figure 7a).
Function of T cells was analyzed by their capability to
produce interferon (IFN)-g. CD3þ cells producing IFN-g
were mostly GFPdonor cells at 3 h of I/R injury, but quickly
shifted to GFPþ host T cells at 12 h. At 10 weeks, one third of
GFPþ host T cells were able to produce IFN-g. Frequencies
of IFN-g–producing host T cells were similar among CD4þ
and CD8þ T cells (Figure 7c).
DISCUSSION
Renal I/R injury, which occurs in some degree in every
transplant graft, is a significant deleterious factor responsible
for early poor graft function as well as for late graft loss due
to chronic inflammation and fibrosis, characterized as IF/TA.
To understand the mechanisms by which acute I/R injury
results in continual adaptive immune responses, the current
study focused on graft renal DC alteration and host DC
infiltration during acute and late phases of KTx-induced
renal I/R injury. DCs are known to have crucial roles in
regulating normal and abnormal immune functions. Numer-
ous studies have described the roles of DCs in lymphoid
tissues during steady-state as well as various disease
conditions; however, relatively little is known about the roles
of tissue-resident DCs, particularly in the kidney. Previous
histopathological studies show that normal kidney DCs
form a contiguous network throughout the entire inter-
stitium and create an anatomic surveillance network to sense
and respond to substances diffusing into the kidney.11,12,14
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Figure 6 |Host (GFPþ ) cell infiltrations into kidney grafts. Wild type (WT) to green fluorescent protein (GFP) kidney transplantation (KTx)
was performed with or without 24-h cold storage in UW (University of Wisconsin) solution (24h-CS, no-CS groups). Kidney grafts were
obtained at 3 h, 12 h, 4 weeks, and 10 weeks after KTx (N¼ 2–4 for each time point in no-CS and N¼ 4–6 in 24h-CS groups) for
immunohistochemistry and flow cytometry. (a) Percentages of GFPþ host cells in isolated CD45þ leukocytes from kidney grafts.
Significantly more GFPþ cells were seen in 24h-CS than in no-CS grafts. *Po0.05, #Po0.005. (b) Kidney graft sections were examined for
GFPþ cells with nuclear Hoechst stain (blue). GFPþ host cells increased with time and numerous GFPþ infiltrates were seen in 24h-CS grafts
at 10 weeks. (c) Percentages of CD3þ T cells in graft CD45þ leukocytes. T cells increased with time and were significantly more in 24h-CS
than in no-CS grafts. *Po0.05, #Po0.005. (d) Immunohistochemistry for CD3 (red) with nuclear Hoechst stain (blue). Significant host (GFPþ )
T-cell infiltration (arrows) in 24h-CS grafts at 10 weeks after KTx. Control no-CS grafts showed few CD3þ T cells. Lower panels show images
of green GFP channel and red CD3 channel.
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In vitro analyses of isolated renal DCs have shown that they
are in immature status (low costimulatory function) and
possess full phagocytic ability.10 These studies certainly have
established the location and phenotypes of renal DCs;
however, in vivo functional roles of renal DCs are not
defined.
Using the WT to GFP transgenic rat KTx model, which
enabled us to differentiate donor kidney-resident DCs from
recruited host DCs, we demonstrate here an early loss of
GFP donor renal DCs and progressive GFPþ host DC
infiltration into the kidney grafts with I/R injury. At 4–10
weeks after initial I/R injury, the majority of donor renal DCs
disappear from 24h-CS grafts, and CD11b/cþ cells in these
kidney grafts become nearly totally GFPþ host phenotype,
which are located among inflammatory infiltrates, and do
not form the interstitial network. In contrast, control grafts
without I/R injury maintain the interstitial network of donor
phenotype renal DCs for 10 weeks with significantly less host
DC infiltration. These results suggest that kidney-resident
DCs and recruited systemic DCs have different functional
roles. Infiltrating host DCs promote fibroinflammatory
reactions, whereas renal-resident DCs might have protective
roles in regulating chronic inflammation and infiltration of
host DCs. Although further investigation is needed, renal-
resident DCs could be involved in the control of renal
microenvironment and regulation of adaptive immune
responses.
We have identified two subpopulations of renal DCs in
normal rat kidneys, predominant CD103CD11b/cþ and
minor CD103þCD11b/cþ DCs, and they behave differently
in responding to KTx-induced renal I/R injury.
GFPCD103þ DCs quickly disappear from both 24h-CS
and control no-CS grafts, regardless of injury. In contrast,
GFPCD103 DCs are maintained in no-CS grafts, but
disappear from 24h-CS grafts with I/R injury. Recent studies
show that DCs exhibit distinct functional roles depending on
CD103 (integrin aE) expression; CD103
 DCs are highly
qualified to perform innate mechanisms such as antigen
clearance and chemokine-mediated attraction of leukocytes.
In contrast, CD103þ DCs are primarily involved in cross-
presentation of self or foreign antigens after migrating to
draining lymph nodes.34,35 E-cadherin, the ligand for CD103,
mediates calcium-dependent cell–cell adhesion, and DC
maturation, function, and migration are suggested to be
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Figure 7 |Characterization of host (GFPþ ) T cells in kidney grafts with ischemia/reperfusion (I/R) injury. (a) Analysis of host infiltrating
T cells (GFPþCD45þCD3þ ) for CD4/CD8 and CD62L/CD45RC. CD4þ T cells gradually increased in 24h-CS grafts. Host T cells were mainly
CD4þ CD62LCD45RC effector-memory phenotype T cells. (b) CD4/CD8 ratios were significantly higher in 24h-CS than in no-CS grafts
at 4 and 10 weeks (N¼ 2–4 for each time point in no-CS and N¼ 4–6 in 24h-CS groups). *Po0.05. (c) Intracellular interferon-g (IFN-g)
expression on CD45þ leukocytes from kidney grafts. Early after kidney transplantation (KTx) at 3 h, IFN-g was detected in GFPCD3þ
graft T cells. At 10 weeks, GFPþ host T cells produced IFN-g. In GFPþCD3þ cells in 24h-CS grafts at 10 weeks, both CD4þ and CD8þ
T cells were able to produce IFN-g. N¼ 2–4 for each time point in no-CS and N¼ 4–6 in 24h-CS groups. GFP, green fluorescent protein;
LN, lymph node.
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connected to E-cadherin.36 In Langerhans cell cultures, IL-1,
TNF-a, and lipopolysaccharide decrease E-cadherin expres-
sion and dissociate DC aggregates with increased expressions
of MHC class II, CD40, and CD86, suggesting that in vivo DC
migration with cytokines/lipopolysaccharide might be caused
by a loss of E-cadherin–mediated adhesion.37–39 It is long
known that MHC class IIþ DCs disappear from non-
lymphoid tissues as early as 4 h and maximum of 48 h after
lipopolysaccharide, IL-1, or TNF-a injection.40 It is also
shown that renal DCs migrate to T-cell areas of draining
lymph nodes to promote antigen-specific T-cell prolifera-
tion.41 In organ transplantation, the migration of donor DCs
from allografts to recipient lymphoid tissues has been well
documented.42,43 Although these studies do not differentiate
CD103þ and CD103 DCs, the migration from the peri-
pheral tissues to the lymphoid organs after antigen/pathogen
exposure is an essential feature of tissue-resident DCs. The
disappearance of renal CD103þ DCs with migratory features
in both no-CS and 24h-CS grafts in this study could be
caused by KTx and might be involved in T-cell activation. In
contrast, the mechanisms of CD103 renal DC loss in 24h-
CS, but not in no-CS, grafts remain to be determined. As we
find negligible frequencies of donor cells in host spleens after
I/R injury (Ozaki KS et al., unpublished observation), massive
loss of this population may not be caused by migration. It is
tempting to speculate that CD103 DCs might die after being
involved in innate responses to clean antigens and produce
cytokines/chemokines, such as TNF-a, as shown in this study.
Although the information on the turnover of DCs in non-
lymphoid tissues is limited, several studies have shown that
DC homeostasis in the non-lymphoid tissues requires
constant replacement with new cells. Similar to findings in
the lymphoid tissues,44,45 kidney DC turnover was trucked
with 5-bromo-2-deoxyuridine labeling, with bone marrow
transplantation into irradiated recipients, and with para-
biosis.35,46,47 In the steady state, both CD103þ and CD103
DCs undergo limited numbers of divisions and are entirely
replaced within 2–4 weeks by DC precursors most likely from
blood.35 However, in the current study, donor type graft
CD103 DCs were maintained for 10 weeks in syngeneic
recipients with minimum graft injury. We also observed the
same maintenance of kidney graft–resident CD103 DCs in
allogeneic recipients under the control of rejection with
tacrolimus (Ozaki KS et al., unpublished data). Epidermal
Langerhans cells were shown to remain as host type for
at least 18 months in bone marrow chimera, and in parabiotic
mice with shared blood circulation, there was no mixing of
skin Langerhans cells,48 suggesting that under steady-state
conditions, Langerhans cells can be locally maintained. Further
study is warranted to identify the mechanisms in maintaining
kidney-resident CD103 DCs. It is intriguing to investigate
the possibility that kidney CD103 DCs are maintained in
part by local self-renewing progenitors that divide in situ.
Progressive T-cell infiltration in 24h-CS grafts is caused by
accumulation of CD62LCD45RC effector-memory phe-
notype host CD4 T cells. These GFPþ infiltrating T cells
most likely include both antigen-specific (e.g., injury-
associated antigens, self antigens) and non-specifically
activated T cells. Previous mouse studies report continual
presence of effector/memory T cells in the kidney with renal
warm ischemia.49–51 These T cells could have roles in
promoting IF/TA development; however, T-cell depletion
starting 3 days after mouse warm I/R injury increased IL-1
and did not show long-term protective effects.49,50,52 Further
studies to understand roles of CD4þ memory T cells in
kidney grafts, their specificity, and activation signals will be
important to advance our understanding of late graft loss
with IF/TA and to develop therapeutic strategies to prevent/
treat IF/TA and other renal fibroinflammatory conditions.
The current study uses the syngeneic KTx model to
exclusively study the effects of ischemic injury without
any additional factor influencing the endpoints, such as
immunosuppression and alloimmunity. These factors are
unavoidably involved in clinical transplantation and could
significantly influence I/R injury and graft outcomes. In
accordance with previous studies,53–56 current ongoing study
in the allotransplantation model suggests augmented graft
injury in allogeneic than in syngeneic kidney grafts. Renal-
resident CD103 DCs were not detected in allografts
with I/R injury, while they were maintained in those without
injury (Ozaki KS et al., unpublished data). Further studies
identifying the contributing factors and mechanisms of I/R
injury in allografts would be beneficial to improve outcomes
of clinical KTx.
In summary, using the WT to GFP rat KTx model, the
study demonstrates that renal cold I/R injury resulted in the
early loss of kidney graft–resident CD103CD11b/cþ and
CD103þCD11b/cþ DCs, while CD103 renal DCs were
maintained in grafts without I/R injury. Progressive infiltra-
tion of host DC and CD4þ T cells with effector/effector-
memory phenotypes (CD62LCD45RC) occurred during
the following 10 weeks after I/R injury and was associated
with an upregulation of fibroinflammatory mediators and
histopathological IF/TA development. As the loss of renal
graft–resident DCs due to acute innate I/R injury associates
with a shift to adaptive immunity and chronic inflammation,
renal-resident DCs might function as a protective regulatory
network against profibroinflammatory changes and host DC
infiltration. The current experimental study uses young
animals, and the impact of I/R injury on kidney grafts
obtained from healthy animals cannot be extended to that of
cold ischemic injury on a damaged elderly human kidney.
However, the study provides new insight into mechanisms of
persistent renal I/R injury and roles of renal-resident DCs.
MATERIALS AND METHODS
Reagents
Phycoerythrin, allophycocyanin (APC), Pacific Blue (PB), Alexa
Fluor 647, Alexa Fluor 700, and phycoerythrin/Cy7-conjugated
monoclonal antibodies (mAbs) used in this study included anti-rat
CD3, CD4, CD8, CD11b/c, CD45, CD45R, CD45RC, CD62L, CD86,
CD103, CD161a, IFN-g, and TNF-a obtained from eBioscience
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(San Diego, CA), Serotec (Oxford, UK), and BD Pharmingen
(San Diego, CA). RPMI 1640, L-glutamine, phosphate-buffered
saline, and fetal bovine serum were from Cellgro Mediatech,
(Manassas, VA). 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic
acid buffer and gentamicin were from Life Technologies (Grand
Island, NY). Collagenase (Type IV), phorbol 12-myristate 13-
acetate, calcium ionomycin, paraformaldehyde, and saponin were
obtained from Sigma (St Louis, MO). Golgi Plug (BD Pharmingen)
and sodium azide (Fisher Scientific, Fair Lawn, NJ) also were used.
Animals and surgical procedures
A breeding colony of GFP transgenic and WT Sprague–Dawley rats,
originally generated by Dr Masaru Okabe (University of Osaka,
Osaka, Japan),57 was maintained at the University of Pittsburgh. All
procedures in this experiment were performed according to the
guidelines of the National Research Council’s Guide for the Humane
Care and Use of Laboratory Animals, and approved by the Council
on Animal Care at the University of Pittsburgh.
Orthotopic KTx was performed using GFP transgenic rats as
recipients and WT as donors using the technique described
previously.31 The donor left kidney was flushed with 3ml UW
solution (Du Pont, Wilmington, DE) and transplanted either
immediately or after 24 h preservation in UW solution at 4 1C into
the recipient by end-to-side anastomoses to recipient infrarenal
abdominal aorta and infrarenal vena cava. The recipient left native
kidney was removed, and end-to-end ureteral anastomosis was
performed. Graft samples were obtained during the early phase at 3
and 12 h, and late phase at 4 and 10 weeks.
Renal leukocyte isolation
Renal leukocytes were isolated from the kidney by the collagenase
digestion method. Briefly, the kidney was perfused in situ with 25ml
phosphate-buffered saline, excised, and then cut into small pieces in
RPMI 1640 containing 5% fetal bovine serum, L-glutamine,
25mmol/l 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid,
4 mg/ml gentamycin, and 0.05% collagenase. After incubation for
30min at 37 1C, cells were filtrated through a 70-mm filter, and
leukocytes were separated by low-speed centrifugation (five times at
500 r.p.m./5min/4 1C) and obtained by high-speed centrifugation
(1500 r.p.m./10min/4 1C).
Flow cytometry
Isolated renal leukocytes were incubated with mAbs at 4 1C for
30min and analyzed on an LSR (BD Biosciences). Data were
analyzed using Flowjo 7.5 (Tree Star, Oregon Corporation, Ashland,
OR). TNF-a–producing cells were detected after culturing isolated
leukocytes (106 cells/100ml) with Golgi Plug for 6 h at 37 1C. For
the detection of IFN-g, leukocytes were incubated with phorbol
12-myristate 13-acetate, calcium ionomycin, and Golgi Plug for 6 h
at 37 1C. At the end of 6 h, cells were washed, incubated with mAbs
for surface markers, fixed with 2% paraformaldehyde, permiabilized
with 0.1% saponin, and incubated with anti-TNF-a or IFN-g mAbs
at 4 1C.
Polymerase chain reaction
After total RNA was extracted from the graft tissues and cDNA was
prepared, mRNA expression was quantified by SYBR Green two-
step, real-time reverse-transcription polymerase chain reaction as
previously described.58 The expression of each gene was normalized
to GAPDH mRNA content and was calculated relative to normal
control using DD Ct method.59,60
Routine pathology and IHC
The kidney samples were stored in 2% paraformaldehyde at 4 1C,
then in 2.3mol/l sucrose in phosphate-buffered saline overnight,
embedded in optimal cutting temperature compound, and frozen in
liquid nitrogen–cooled isopentane. Samples were cut into 6-mm
sections, blocked with superblock (ScyTek Lab, Logan, UT), and
stained with mAbs for a-smooth muscle actin, CD3, CD11b/c, and
neutrophils (RP-1). Sections were nuclear DNA stained with
Hoechst dye (Bisbenzimide), coverslipped with Gelvatol, and
visualized with an Olympus BX51 epifluorescence microscope or a
Fluoview 1000 confocal microscope (Olympus, Center Valley, PA).
Data analysis
Results are expressed as means±s.d. Statistical analysis was
performed using Student’s t-test or one-way analysis of variance
where appropriate. A probability level of Po0.05 was considered
statistically significant.
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